These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14959528)

  • 1. Play fair. Ark. AG accuses Blues of monopolizing local market.
    Benko LB
    Mod Healthc; 2004 Jan; 34(3):18-9. PubMed ID: 14959528
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ball Memorial Hospital: Section 2 Sherman Act analysis in the alternative health care delivery market.
    Kirsch T
    Am J Law Med; 1988; 14(2-3):249-79. PubMed ID: 3072878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deselected doctors vs. the Blues: who really won?
    Pretzer M
    Med Econ; 1995 Oct; 72(19):182-3, 187-8, 192. PubMed ID: 10152021
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 7. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
    Baker JB
    Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrowing provider choice: any willing provider laws after New York Blue Cross v. Travelers.
    McCarthy D
    Am J Law Med; 1997; 23(1):97-113. PubMed ID: 9199734
    [No Abstract]   [Full Text] [Related]  

  • 9. Legal. Experts debate the impact of antitrust suit against Michigan Blues.
    Taylor M
    Hosp Health Netw; 2010 Dec; 84(12):12, 14. PubMed ID: 21268792
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical care at predetermined prices does not violate antitrust laws.
    Rothschild IS
    Health Law Vigil; 1987 Apr; 10(9):5-6, 12. PubMed ID: 10281338
    [No Abstract]   [Full Text] [Related]  

  • 11. Nine N.J. hospitals suing Blues to block network.
    Pallarito K
    Mod Healthc; 1993 Jul; 23(28):6. PubMed ID: 10126911
    [No Abstract]   [Full Text] [Related]  

  • 12. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 13. The Marshfield Clinic case: the sound of a broken record.
    McDonald K
    Ann Health Law; 1996; (5):1-31. PubMed ID: 10184656
    [No Abstract]   [Full Text] [Related]  

  • 14. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 15. Market share/market power revisited. A new test for an old theory.
    Staten M; Umbeck J; Dunkelberg W
    J Health Econ; 1988 Mar; 7(1):73-87. PubMed ID: 10288443
    [No Abstract]   [Full Text] [Related]  

  • 16. Provider suits against Blues sponsored PPOs prompt counterattack.
    Steele CJ
    Bus Health; 1985 May; 2(6):49. PubMed ID: 10271267
    [No Abstract]   [Full Text] [Related]  

  • 17. Blue on Blues.
    Edlin M
    Hosp Health Netw; 1998 May; 72(9):31-3. PubMed ID: 9646734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenn. Blues drop Erlanger as PPO provider.
    Gardner E
    Mod Healthc; 1992 Mar; 22(11):12. PubMed ID: 10116797
    [No Abstract]   [Full Text] [Related]  

  • 19. Do "any willing provider" and "freedom of choice" laws affect HMO market share?
    Morrisey MA; Ohsfeldt RL
    Inquiry; 2003; 40(4):362-74. PubMed ID: 15055835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On "FTC Sings the Blues" and its respondents.
    Weller CD
    J Health Polit Policy Law; 1982; 7(2):547-58. PubMed ID: 7108176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.